Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Cityblock Health on the deal. Cityblock Health, a US-based healthcare provider that caters to Medicaid and lower-income...
Cityblock Health’s $192 Million Series C-2 Financing
Tarsus Pharmaceuticals’ Strategic Partnership with LianBio
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Tarsus Pharmaceuticals, Inc. on the deal. Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late clinical-stage biopharmaceutical company, and...
Pyxis Oncology’s $152M Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Pyxis Oncology on the deal. Pyxis Oncology (“Pyxis” or the “Company”) announced the closing of a $152 million...
Amgen’s Acquisition of Rodeo Therapeutics
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Amgen Inc on the deal. Amgen Inc (NASDAQ:AMGN) announced its acquisition of Rodeo Therapeutics. Amgen is one of...
Resolve Growth Partners’ Fundraising
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Resolve Growth Partners on the deal. Resolve Growth Partners announced the formation of its inaugural funds, Resolve Growth...
Resolve Growth Partners’ Fundraising
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Resolve Growth Partners on the deal. Resolve Growth Partners announced the formation of its inaugural funds, Resolve Growth...
MaC Venture Capital’s $110 Million Fundraising
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised MaC Venture Capital on the deal. MaC Venture Capital announced the formation of its $110 million inaugural fund....
Khatabook’s $10 Million Acquisition of Biz Analyst
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Khatabook on the deal. India-based fintech company Khatabook has acquired Biz Analyst, a software-as-a-service business management firm, in...
Boston Pharma’s Llicense Arrangement with GSK
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Boston Pharma on the deal. Boston Pharma, a clinical stage biopharmaceutical company developing differentiated therapeutics, announced its strategic...
Corvus Insurance’s $100M Series C Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Corvus Insurance on the deal. Corvus Insurance, the leading provider of smart commercial insurance products powered by...
Apna.co’s $12.5 Million Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Sequoia India, Lightspeed India and Greenoaks on the deal. Apna.co, a vertical professional networking platform, announced that...
Turntide Technologies’ Acquisition of Riptide
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP advised Turntide Technologies on the deal. Turntide Technologies (Turntide), the company responsible for the Smart Motor System, the...